For Tuesday, May 11, WGN’s Medical Reporter Dina Bair has the latest on new information including:
- University of Alberta virologists tested the medication and found it attacks SARS CoV-2, the virus that causes COVID-19. It works by changing the viral genome of the virus – -essentially creating an error catastrophe for the replicating germ.
- Some sobering news when it comes to serious Covid infections. Eight out of 10 people hospitalized with COVID-19 develop neurological problems.
A study by University of Pittsburgh researchers found neurological ramifications in active infection and among survivors.
- An ultrasensitive test can diagnose Covid and the flu with one swab.
Developed by University of California Santa Cruz scientists, the chip based antigen test identifies SAR CoV-2 and Influenza-A.
- There is a demographic shift in serious COVID-19 cases to report. After spending much of the past year treating elderly patients, doctors are now seeing more young and middle-aged adults.
- A study out of Brazil concludes high doses of Vitamin D don’t have any effect on people in the hospital suffering with moderate to severe COVID-19 symptoms.
- There’s a big connection between the gut and the brain. It turns out microorganisms living in the gut can affect mood and may even provide links to anxiety and depression. A new study suggests a type of prebiotic could reduce anxiety in some females in late adolescence through changes in their gut microorganisms.